The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparing NCCN-based risk groups to the PROTEUS definition of high-risk localized prostate cancer to inform peri-operative care.
 
David-Dan Nguyen
No Relationships to Disclose
 
Christopher Wallis
Honoraria - Abbvie; Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; EMD Serono; Haymarket Medical Education; Knight Therapeutics; Merck; Tersera; Tolmar
Consulting or Advisory Role - Janssen Oncology; Nanostics; Precision Point Specialty; Sesen Bio
Research Funding - Bayer (Inst); Knight Therapeutics (Inst); Tolmar (Inst)
Travel, Accommodations, Expenses - Janssen; Knight Therapeutics; Knight Therapeutics; Tersera; Tolmar; Verity Pharmaceuticals
 
Bobby Shayegan
Consulting or Advisory Role - Abbvie; Astellas Pharma; Bayer; Janssen Oncology; Knight Pharmaceuticals; Novartis Canada Pharmaceuticals Inc; Novartis Canada Pharmaceuticals Inc; Tersera; Tolmar
 
Aly-Khan Lalani
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Merck; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - Abbvie; Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Janssen; Merck; Novartis; Pfizer
Research Funding - BioCanRx (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Ipsen (Inst); Novartis (Inst); Roche (Inst)
 
Geoffrey Gotto
Honoraria - Astellas Pharma; AstraZeneca; Bayer; EMD Serono; Ferring; Janssen; McKesson; Merck; Pfizer; Sanofi; Tolmar
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; EMD Serono; Ferring; Janssen; McKesson; Merck; Pfizer; Sanofi; Tolmar
Research Funding - Janssen
Expert Testimony - Janssen
Travel, Accommodations, Expenses - Janssen
 
Amanda Hird
No Relationships to Disclose
 
Andrea Kokorovic
Honoraria - AstraZeneca; Bayer; Janssen; Tersera
Consulting or Advisory Role - Astellas Pharma; Bayer; EMD Serono; Ferring; Janssen; Knight Therapeutics; Pfizer; Tersera; Tolmar
Travel, Accommodations, Expenses - Janssen; Tersera
 
Melissa Huynh
Honoraria - Astellas Oncology; Knight Therapeutics
 
Andrew Feifer
No Relationships to Disclose
 
Ricardo Rendon
Stock and Other Ownership Interests - Myovant Sciences
Honoraria - Astellas Pharma; Bayer; Janssen; Sanofi
Speakers' Bureau - Astellas Pharma; Bayer; Janssen
 
Rodney Breau
Honoraria - Astellas Amgen BioPharama; Eisai; Knight Therapeutics; Merck; TerSera; Tolmar
Research Funding - Tolmar
 
Antonio Finelli
Stock and Other Ownership Interests - Abbvie; Medtronic
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen Oncology; Merck; Tersera
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen Oncology; Tersera
 
Neil Fleshner
Leadership - POINT Biopharma; Verity Pharmaceuticals
Stock and Other Ownership Interests - Verity Pharmaceuticals
Honoraria - Abbvie; Amgen; Astellas Medivation; Bayer; Ferring; Janssen; Sanofi
Consulting or Advisory Role - Hybridyne Health
Research Funding - Amgen (Inst); Astellas Medivation (I); Ferring (Inst); Janssen (Inst); nucelix (Inst); Progenix (Inst); Sanofi (Inst); Spectracure (Inst)
 
Alexandre Zlotta
Honoraria - miR Scientific; Theralase; Verity Pharmaceuticals
Consulting or Advisory Role - AstraZeneca Canada; BioSyent; Ferring; Merck; miR Scientific; Sanofi; Theralase; Verity Pharmaceuticals
Research Funding - AstraZeneca Canada (Inst); Ferring (Inst); Merck (Inst); Sanofi (Inst); Verity Pharmaceuticals (Inst)